Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.600
+0.010 (0.39%)
At close: Jun 27, 2025, 4:00 PM
2.540
-0.060 (-2.31%)
After-hours: Jun 27, 2025, 6:35 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $104.67 million as of June 27, 2025. Its market cap has decreased by -58.16% in one year.
Market Cap
104.67M
Enterprise Value
72.92M
1-Year Change
-58.16%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $104.67M, a decrease of -92.15%. That is a compound annual growth rate of -41.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 104.67M | -60.96% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.69B |
| Johnson & Johnson | 365.70B |
| AbbVie | 329.73B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.65B |
| Abbott Laboratories | 231.75B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |